Tag Archives: progression-free

First-Line Erlotinib Triples Progression-Free Survival in NSCLC in Chinese Population

First-line erlotinib (Tarceva) tripled the progression-free survival in advanced non–small cell lung carcinoma (NSCLC) patients who had endothelial growth factor receptor (EGFR)-activating mutation, according to the OPTIMAL study presented at the 35th European Society for Medical Oncology Congress. The study … Continue reading

Posted in Cancer, Lung Cancer, Non Small Cell Lung Cancer | Tagged , , , , , , , , , , | Comments Off on First-Line Erlotinib Triples Progression-Free Survival in NSCLC in Chinese Population